{"hands_on_practices": [{"introduction": "The choice of specimen collection tube represents the first, and one of the most critical, pre-analytical decisions in the diagnostic workflow. While anticoagulants are essential for obtaining plasma or whole blood, they are active chemical agents that can interfere with downstream assays. This practice [@problem_id:5164443] provides a hands-on opportunity to apply fundamental chemical principles, such as calculating molar concentrations, to determine the effective concentration of EDTA in a plasma sample and predict its powerful chelating effect on divalent cations like $\\text{Mg}^{2+}$, a critical cofactor for many enzymes used in molecular diagnostics.", "problem": "A clinical molecular and immunodiagnostics laboratory uses dipotassium ethylenediaminetetraacetate ($K_2\\text{EDTA}$; ethylenediaminetetraacetic acid) anticoagulant tubes for whole blood collection. A technologist collects $3\\,\\mathrm{mL}$ of whole blood into a tube containing $5\\,\\mathrm{mg}$ of dry $K_2\\text{EDTA}$. Assume the following realistic conditions aligned with specimen processing and stability constraints:\n\n- The whole blood hematocrit is $H = 0.45$; plasma volume is the non-cellular fraction of the whole blood volume.\n- $K_2\\text{EDTA}$ dissolves completely and distributes uniformly in plasma.\n- The molar mass of $K_2\\text{EDTA}$ dihydrate is $M_{\\mathrm{K_2\\text{-}EDTA}} = 404.45\\,\\mathrm{g/mol}$.\n- Before EDTA exposure, the free magnesium ion concentration in plasma is $C_{\\mathrm{Mg}^{2+},0} = 0.60\\,\\mathrm{mM}$.\n- Ethylenediaminetetraacetic acid chelates divalent cations in $1{:}1$ stoichiometry with sufficiently large formation constants under physiological pH that, when EDTA is in molar excess over a given free divalent cation, that cation’s free concentration can be treated as driven effectively to zero for the purposes of assessing enzyme cofactor availability.\n\nUsing fundamental definitions of moles and concentration, compute the final EDTA concentration in plasma after mixing. Then, based on the computed EDTA concentration and the stoichiometric chelation assumption above, assess the likely impact on the availability of $\\mathrm{Mg}^{2+}$ for $\\mathrm{Mg}^{2+}$-dependent enzymes commonly used in molecular and immunodiagnostics workflows.\n\nRound your final numeric answer to three significant figures and express it in millimolar (mM). Provide only the computed EDTA concentration as your final numeric answer.", "solution": "The goal is to compute the molar concentration of dipotassium ethylenediaminetetraacetate ($K_2\\text{EDTA}$) in plasma after mixing and then use first-principles reasoning about chelation stoichiometry to assess the effect on free $\\mathrm{Mg}^{2+}$.\n\nStart from core definitions:\n\n1. The number of moles is given by $n = \\frac{m}{M}$, where $m$ is mass and $M$ is molar mass.\n2. Concentration is defined as $C = \\frac{n}{V}$, where $V$ is the volume of the solution in which the solute is dissolved.\n3. Hematocrit $H$ is the cellular volume fraction of whole blood, so plasma volume is $V_{\\mathrm{plasma}} = (1 - H)\\,V_{\\mathrm{blood}}$.\n\nStep 1: Compute plasma volume. The whole blood volume is $V_{\\mathrm{blood}} = 3\\,\\mathrm{mL} = 0.003\\,\\mathrm{L}$. The hematocrit is $H = 0.45$, thus\n$$\nV_{\\mathrm{plasma}} = (1 - H)\\,V_{\\mathrm{blood}} = (1 - 0.45)\\times 0.003\\,\\mathrm{L} = 0.55 \\times 0.003\\,\\mathrm{L} = 0.00165\\,\\mathrm{L}.\n$$\n\nStep 2: Compute moles of $K_2\\text{EDTA}$. The mass of $K_2\\text{EDTA}$ is $m = 5\\,\\mathrm{mg} = 5 \\times 10^{-3}\\,\\mathrm{g}$, and the molar mass is $M_{\\mathrm{K_2\\text{-}EDTA}} = 404.45\\,\\mathrm{g/mol}$. Therefore,\n$$\nn_{\\mathrm{EDTA}} = \\frac{m}{M_{\\mathrm{K_2\\text{-}EDTA}}} = \\frac{5 \\times 10^{-3}\\,\\mathrm{g}}{404.45\\,\\mathrm{g/mol}} \\approx 1.2366 \\times 10^{-5}\\,\\mathrm{mol}.\n$$\n\nStep 3: Compute EDTA concentration in plasma. Using $C = \\frac{n}{V}$,\n$$\nC_{\\mathrm{EDTA}} = \\frac{n_{\\mathrm{EDTA}}}{V_{\\mathrm{plasma}}} = \\frac{1.2366 \\times 10^{-5}\\,\\mathrm{mol}}{0.00165\\,\\mathrm{L}} \\approx 7.4946 \\times 10^{-3}\\,\\mathrm{mol/L} = 7.4946\\,\\mathrm{mM}.\n$$\nRounded to three significant figures, this is $7.49\\,\\mathrm{mM}$.\n\nStep 4: Assess impact on $\\mathrm{Mg}^{2+}$-dependent enzymes. The initial free magnesium ion concentration in plasma is $C_{\\mathrm{Mg}^{2+},0} = 0.60\\,\\mathrm{mM}$. Under the stated assumption of large formation constants and $1{:}1$ stoichiometry, when ethylenediaminetetraacetic acid is present in excess over free divalent cations, it will chelate them stoichiometrically. Here, $C_{\\mathrm{EDTA}} \\approx 7.49\\,\\mathrm{mM}$ is far greater than $0.60\\,\\mathrm{mM}$, so the EDTA is in substantial excess over free $\\mathrm{Mg}^{2+}$ and, in practice, will reduce the free $\\mathrm{Mg}^{2+}$ concentration toward $0\\,\\mathrm{mM}$.\n\nMany enzymes used in molecular and immunodiagnostics workflows, such as deoxyribonucleic acid (DNA) polymerases in polymerase chain reaction and certain kinases or phosphatases, require micromolar to millimolar free $\\mathrm{Mg}^{2+}$ as a cofactor for catalysis and substrate binding. Driving free $\\mathrm{Mg}^{2+}$ effectively to zero by EDTA chelation would severely impair or abrogate catalytic activity, thus adversely affecting assay performance and stability. Therefore, the computed EDTA concentration implies a strong likelihood of inhibition for $\\mathrm{Mg}^{2+}$-dependent enzymes in specimens collected with EDTA anticoagulant.\n\nThe requested final numeric answer is the EDTA concentration in millimolar, rounded to three significant figures:\n$$\nC_{\\mathrm{EDTA}} \\approx 7.49\\,\\mathrm{mM}.\n$$", "answer": "$$\\boxed{7.49}$$", "id": "5164443"}, {"introduction": "The stability of target analytes is a cornerstone of reliable diagnostic testing, with molecules like ribonucleic acid (RNA) being notoriously susceptible to degradation. Delays between specimen collection and stabilization can introduce significant pre-analytical error, compromising the integrity of the sample. This exercise [@problem_id:5164432] allows you to quantitatively model this process by applying first-order degradation kinetics and the $Q_{10}$ temperature coefficient rule, providing a practical method for estimating the impact of a processing delay at room temperature on the RNA Integrity Number (RIN), a key metric of sample quality for genomic applications.", "problem": "A fresh human tissue biopsy is collected for ribonucleic acid (RNA) profiling in a molecular diagnostics workflow. Before immersion in a lysis buffer that inactivates endogenous ribonucleases, the specimen is inadvertently kept at room temperature (RT) for $30$ min. You are asked to estimate the resulting drop in the RNA Integrity Number (RIN), where the RIN is a unitless metric on a $1$ to $10$ scale.\n\nAssume the following scientifically grounded conditions hold:\n\n- RNA degradation in the intact tissue prior to lysis follows first-order kinetics with respect to the remaining intact RNA.\n- At $4^{\\circ}\\mathrm{C}$, the degradation half-life of intact RNA prior to lysis is $8$ h.\n- The temperature coefficient $Q_{10}$ for the degradation rate constant is $2$.\n- Room temperature is $22^{\\circ}\\mathrm{C}$.\n- At $t=0$ (immediately post-excision, before any delay), the specimen has $\\text{RIN}_{0} = 9.5$.\n- For the purpose of this estimate, the RIN is linearly proportional to the fraction of intact RNA and attains $\\text{RIN} = 1$ for completely degraded RNA and $\\text{RIN} = \\text{RIN}_{0}$ at $t=0$.\n\nUsing only these assumptions and standard physical chemistry relations, compute the predicted decrease in RIN after the $30$ min RT delay prior to lysis. Report the result as a unitless number, and round your answer to three significant figures.", "solution": "The problem statement is evaluated to be valid. It is scientifically grounded, well-posed, and internally consistent, providing all necessary information for a unique solution.\n\nThe degradation of intact ribonucleic acid (RNA) is modeled as a first-order kinetic process. Let $N(t)$ be the amount of intact RNA at time $t$, and $N_0$ be the initial amount at $t=0$. The differential rate law for a first-order reaction is:\n$$\n\\frac{dN}{dt} = -kN\n$$\nwhere $k$ is the first-order rate constant. Integration of this equation yields the relationship between the amount of intact RNA and time:\n$$\nN(t) = N_0 \\exp(-kt)\n$$\nThe fraction of intact RNA, $f(t)$, remaining at time $t$ is given by:\n$$\nf(t) = \\frac{N(t)}{N_0} = \\exp(-kt)\n$$\nThe rate constant $k$ is temperature-dependent. We are provided with the degradation half-life, $t_{1/2, \\text{ref}} = 8$ hours, at a reference temperature $T_{\\text{ref}} = 4^{\\circ}\\mathrm{C}$. The relationship between the half-life and the rate constant for a first-order process is:\n$$\nk = \\frac{\\ln(2)}{t_{1/2}}\n$$\nThus, the rate constant at the reference temperature is:\n$$\nk_{\\text{ref}} = \\frac{\\ln(2)}{8 \\text{ h}}\n$$\nTo determine the rate constant, $k_{\\text{RT}}$, at room temperature, $T_{\\text{RT}} = 22^{\\circ}\\mathrm{C}$, we use the provided temperature coefficient, $Q_{10}=2$. The $Q_{10}$ rule relates the rate constants $k_1$ and $k_2$ at temperatures $T_1$ and $T_2$ (in degrees Celsius) as follows:\n$$\nQ_{10} = \\left(\\frac{k_2}{k_1}\\right)^{\\frac{10^{\\circ}\\mathrm{C}}{T_2 - T_1}}\n$$\nIn our case, $k_1 = k_{\\text{ref}}$, $T_1 = T_{\\text{ref}} = 4^{\\circ}\\mathrm{C}$, $k_2 = k_{\\text{RT}}$, and $T_2 = T_{\\text{RT}} = 22^{\\circ}\\mathrm{C}$. The temperature difference is $\\Delta T = T_{\\text{RT}} - T_{\\text{ref}} = 22^{\\circ}\\mathrm{C} - 4^{\\circ}\\mathrm{C} = 18^{\\circ}\\mathrm{C}$. Substituting the known values:\n$$\n2 = \\left(\\frac{k_{\\text{RT}}}{k_{\\text{ref}}}\\right)^{\\frac{10}{18}}\n$$\nSolving for the ratio of the rate constants:\n$$\n\\frac{k_{\\text{RT}}}{k_{\\text{ref}}} = 2^{\\frac{18}{10}} = 2^{1.8}\n$$\nTherefore, the rate constant at room temperature is:\n$$\nk_{\\text{RT}} = k_{\\text{ref}} \\cdot 2^{1.8} = \\frac{\\ln(2)}{8 \\text{ h}} \\cdot 2^{1.8}\n$$\nThe specimen is kept at room temperature for a duration of $t = 30$ minutes, which is equivalent to $t = 0.5$ hours. The fraction of intact RNA, $f(t)$, remaining after this delay is:\n$$\nf(t) = \\exp(-k_{\\text{RT}} t) = \\exp\\left(-\\left(\\frac{\\ln(2) \\cdot 2^{1.8}}{8 \\text{ h}}\\right) \\cdot (0.5 \\text{ h})\\right) = \\exp\\left(-\\frac{\\ln(2) \\cdot 2^{1.8}}{16}\\right)\n$$\nThe problem states that the RNA Integrity Number (RIN) is linearly proportional to the fraction of intact RNA, $f$. Let this relationship be $\\text{RIN}(f) = mf + c$, where $m$ and $c$ are constants. We are given two boundary conditions:\n1. For completely degraded RNA, $f=0$, the RIN is $1$. This gives $\\text{RIN}(0) = m(0) + c = 1$, which implies $c=1$.\n2. At time $t=0$, the RNA is fully intact, so $f=1$, and the RIN is $\\text{RIN}_0 = 9.5$. This gives $\\text{RIN}(1) = m(1) + c = 9.5$.\n\nSubstituting $c=1$ into the second condition:\n$$\nm + 1 = 9.5 \\implies m = 8.5\n$$\nThus, the linear relationship is:\n$$\n\\text{RIN}(f) = 8.5f + 1\n$$\nWe want to find the decrease in RIN, $\\Delta\\text{RIN}$, which is the difference between the initial RIN and the final RIN after the delay.\n$$\n\\Delta\\text{RIN} = \\text{RIN}_0 - \\text{RIN}_{\\text{final}}\n$$\nThe initial RIN is $\\text{RIN}_0 = \\text{RIN}(1) = 9.5$. The final RIN is $\\text{RIN}_{\\text{final}} = \\text{RIN}(f(t))$.\n$$\n\\Delta\\text{RIN} = 9.5 - (8.5 f(t) + 1) = 8.5 - 8.5 f(t) = 8.5(1 - f(t))\n$$\nSubstituting the expression for $f(t)$:\n$$\n\\Delta\\text{RIN} = 8.5\\left(1 - \\exp\\left(-\\frac{\\ln(2) \\cdot 2^{1.8}}{16}\\right)\\right)\n$$\nNow, we compute the numerical value.\n$$\n\\ln(2) \\approx 0.693147\n$$\n$$\n2^{1.8} \\approx 3.482202\n$$\nThe argument of the exponential function is:\n$$\n-\\frac{\\ln(2) \\cdot 2^{1.8}}{16} \\approx -\\frac{0.693147 \\cdot 3.482202}{16} \\approx -\\frac{2.41375}{16} \\approx -0.150859\n$$\nThe fraction of remaining RNA is:\n$$\nf(t) \\approx \\exp(-0.150859) \\approx 0.860003\n$$\nFinally, we calculate the decrease in RIN:\n$$\n\\Delta\\text{RIN} \\approx 8.5(1 - 0.860003) = 8.5(0.139997) \\approx 1.18997\n$$\nRounding the result to three significant figures, we get $1.19$.", "answer": "$$\n\\boxed{1.19}\n$$", "id": "5164432"}, {"introduction": "Despite stringent protocols, pre-analytical errors such as hemolysis can occur, introducing interfering substances into the specimen that can compromise assay accuracy. This problem moves beyond simple identification of an error to its quantitative assessment and correction, a hallmark of advanced diagnostic practice. This exercise [@problem_id:5164416] challenges you to use the Beer-Lambert law to calculate the specific bias introduced by hemoglobin in an ELISA and to derive a practical, dual-wavelength spectroscopic correction method, demonstrating how analytical principles can be used to rescue and validate results from compromised samples.", "problem": "A laboratory is validating an Enzyme-Linked Immunosorbent Assay (ELISA) that reads at $415\\,\\mathrm{nm}$ in a microplate. During specimen processing, a low level of hemolysis is introduced. The laboratory quantifies hemolysis as two percent, meaning a fraction $\\alpha = 0.02$ of the red blood cell compartment lyses completely and releases hemoglobin into the plasma. Assume whole blood has hematocrit $H_c = 0.45$, the mean corpuscular hemoglobin concentration within red blood cells is $C_{\\mathrm{MCHC}} = 340\\,\\mathrm{g}\\,\\mathrm{L}^{-1}$, and the plasma volume fraction per liter of whole blood is $V_p = 0.55\\,\\mathrm{L}$. The sample volume per microplate well is $200\\,\\mu\\mathrm{L}$, and the effective optical path length is $l = 0.50\\,\\mathrm{cm}$. The ELISA chromogen’s true absorbance (in the absence of hemoglobin) at $415\\,\\mathrm{nm}$ is $A_{\\mathrm{true}} = 0.600$. The molar mass of the hemoglobin tetramer is $M_{\\mathrm{Hb}} = 64{,}500\\,\\mathrm{g}\\,\\mathrm{mol}^{-1}$. Treat the hemoglobin tetramer as a single chromophore with the following apparent molar absorptivities in the plasma matrix: at $415\\,\\mathrm{nm}$, $\\epsilon_{415}^{\\mathrm{Hb}} = 4.0 \\times 10^{4}\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}\\,\\mathrm{cm}^{-1}$; at $700\\,\\mathrm{nm}$ (a reference wavelength where the ELISA chromogen has negligible absorbance), $\\epsilon_{700}^{\\mathrm{Hb}} = 80\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}\\,\\mathrm{cm}^{-1}$. Assume additive absorbances and Beer–Lambert behavior.\n\nUsing only conservation of mass and the Beer–Lambert law, first derive an expression for the plasma free hemoglobin concentration after hemolysis and then use it to quantitatively estimate the bias in the measured ELISA absorbance caused by hemoglobin at $415\\,\\mathrm{nm}$. Define the bias as $b = \\frac{A_{\\mathrm{meas}} - A_{\\mathrm{true}}}{A_{\\mathrm{true}}}$, where $A_{\\mathrm{meas}}$ includes the hemoglobin contribution. Next, propose a two-wavelength optical correction strategy that uses a concurrent measurement at $700\\,\\mathrm{nm}$ to eliminate hemoglobin’s contribution at $415\\,\\mathrm{nm}$, and derive the scaling coefficient $k$ such that $A_{\\mathrm{corr}} = A_{415} - k\\,A_{700}$ recovers $A_{\\mathrm{true}}$ under the stated assumptions.\n\nRound the bias $b$ to three significant figures and the correction coefficient $k$ to three significant figures. Express the final bias as a pure decimal (no percent sign). The final answer must be reported as two values in a single row matrix, with the first entry equal to the bias $b$ and the second entry equal to the coefficient $k$.", "solution": "The problem statement is first subjected to validation.\n\n### Step 1: Extract Givens\n- Assay: Enzyme-Linked Immunosorbent Assay (ELISA)\n- Read wavelength: $415\\,\\mathrm{nm}$\n- Hemolysis fraction: $\\alpha = 0.02$\n- Hematocrit: $H_c = 0.45$\n- Mean Corpuscular Hemoglobin Concentration: $C_{\\mathrm{MCHC}} = 340\\,\\mathrm{g}\\,\\mathrm{L}^{-1}$\n- Plasma volume fraction per liter of whole blood: $V_p = 0.55\\,\\mathrm{L}$\n- Sample volume per microplate well: $200\\,\\mu\\mathrm{L}$\n- Optical path length: $l = 0.50\\,\\mathrm{cm}$\n- True absorbance of chromogen at $415\\,\\mathrm{nm}$: $A_{\\mathrm{true}} = 0.600$\n- Molar mass of hemoglobin tetramer: $M_{\\mathrm{Hb}} = 64{,}500\\,\\mathrm{g}\\,\\mathrm{mol}^{-1}$\n- Molar absorptivity of Hb at $415\\,\\mathrm{nm}$: $\\epsilon_{415}^{\\mathrm{Hb}} = 4.0 \\times 10^{4}\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}\\,\\mathrm{cm}^{-1}$\n- Molar absorptivity of Hb at $700\\,\\mathrm{nm}$: $\\epsilon_{700}^{\\mathrm{Hb}} = 80\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}\\,\\mathrm{cm}^{-1}$\n- Assumption: Additive absorbances and Beer–Lambert behavior.\n- Definition of bias: $b = \\frac{A_{\\mathrm{meas}} - A_{\\mathrm{true}}}{A_{\\mathrm{true}}}$\n- Definition of corrected absorbance: $A_{\\mathrm{corr}} = A_{415} - k\\,A_{700}$\n\n### Step 2: Validate Using Extracted Givens\nThe problem is evaluated for validity.\n- **Scientifically Grounded**: The problem is based on fundamental principles of analytical chemistry (Beer-Lambert law), mass conservation, and hematology. Hemolysis as a pre-analytical interferent in spectrophotometric assays is a well-documented issue in clinical diagnostics. The provided values for hematocrit, MCHC, hemoglobin molar mass, and molar absorptivities are physiologically and physically realistic.\n- **Well-Posed**: The problem provides all necessary data to calculate the requested quantities (bias and correction coefficient). The tasks are clearly defined and lead to a unique solution. The provided information regarding sample volume ($200\\,\\mu\\mathrm{L}$) is contextual and not required for the requested calculations, which are based on concentrations and intensive properties, but its presence does not invalidate the problem.\n- **Objective**: The problem is stated in precise, quantitative terms, free from ambiguity or subjective claims. The assumptions (additive absorbance, ideal Beer-Lambert behavior) are explicitly stated.\n- **Consistency Check**: The hematocrit ($H_c=0.45$) and plasma volume fraction ($V_p=0.55$) sum to $1.00$. This is a common and acceptable simplification in such problems, assuming a negligible volume for the buffy coat. No internal contradictions are present.\n\n### Step 3: Verdict and Action\nThe problem is scientifically sound, well-posed, and objective. It is deemed **valid**. A full solution will be provided.\n\n### Solution Derivation\nThe solution is developed in three parts: first, determining the concentration of free hemoglobin in plasma; second, calculating the resulting absorbance bias; and third, deriving the two-wavelength correction coefficient.\n\n**Part 1: Derivation of Free Hemoglobin Concentration in Plasma**\n\nWe apply the principle of conservation of mass. Let's consider a basis of $1\\,\\mathrm{L}$ of whole blood.\nThe volume of red blood cells (RBCs) in $1\\,\\mathrm{L}$ of whole blood is given by the hematocrit, $H_c$:\n$$V_{\\mathrm{RBC}} = H_c \\times 1\\,\\mathrm{L} = 0.45\\,\\mathrm{L}$$\nThe total mass of hemoglobin contained within these RBCs is determined by the mean corpuscular hemoglobin concentration, $C_{\\mathrm{MCHC}}$:\n$$m_{\\mathrm{Hb, total}} = C_{\\mathrm{MCHC}} \\times V_{\\mathrm{RBC}} = (340\\,\\mathrm{g}\\,\\mathrm{L}^{-1}) \\times (0.45\\,\\mathrm{L}) = 153\\,\\mathrm{g}$$\nA fraction $\\alpha = 0.02$ of the RBCs lyse, releasing their hemoglobin into the plasma. The mass of released hemoglobin is:\n$$m_{\\mathrm{Hb, released}} = \\alpha \\times m_{\\mathrm{Hb, total}} = 0.02 \\times 153\\,\\mathrm{g} = 3.06\\,\\mathrm{g}$$\nThis mass of hemoglobin is distributed throughout the plasma volume. The plasma volume in $1\\,\\mathrm{L}$ of whole blood is given by the plasma volume fraction, $V_p$:\n$$V_{\\mathrm{plasma}} = V_p \\times 1\\,\\mathrm{L} = 0.55\\,\\mathrm{L}$$\nThe mass concentration of free hemoglobin in the plasma, $C_{\\mathrm{Hb, mass}}$, is therefore:\n$$C_{\\mathrm{Hb, mass}} = \\frac{m_{\\mathrm{Hb, released}}}{V_{\\mathrm{plasma}}} = \\frac{3.06\\,\\mathrm{g}}{0.55\\,\\mathrm{L}} \\approx 5.5636\\,\\mathrm{g}\\,\\mathrm{L}^{-1}$$\nFor the Beer-Lambert law, we need the molar concentration, $C_{\\mathrm{Hb}}$. This is obtained by dividing the mass concentration by the molar mass of hemoglobin, $M_{\\mathrm{Hb}}$:\n$$C_{\\mathrm{Hb}} = \\frac{C_{\\mathrm{Hb, mass}}}{M_{\\mathrm{Hb}}} = \\frac{5.5636\\,\\mathrm{g}\\,\\mathrm{L}^{-1}}{64500\\,\\mathrm{g}\\,\\mathrm{mol}^{-1}} \\approx 8.6258 \\times 10^{-5}\\,\\mathrm{mol}\\,\\mathrm{L}^{-1}$$\nSymbolically, the molar concentration of free hemoglobin in plasma is:\n$$C_{\\mathrm{Hb}} = \\frac{\\alpha \\cdot C_{\\mathrm{MCHC}} \\cdot H_c}{V_p \\cdot M_{\\mathrm{Hb}}}$$\n\n**Part 2: Calculation of the Absorbance Bias ($b$)**\n\nThe measured absorbance at $415\\,\\mathrm{nm}$, $A_{\\mathrm{meas}}$, is the sum of the true absorbance from the ELISA chromogen, $A_{\\mathrm{true}}$, and the interfering absorbance from free hemoglobin, $A_{\\mathrm{Hb, 415}}$, due to the assumption of additivity.\n$$A_{\\mathrm{meas}} = A_{\\mathrm{true}} + A_{\\mathrm{Hb, 415}}$$\nThe absorbance from hemoglobin is given by the Beer-Lambert law:\n$$A_{\\mathrm{Hb, 415}} = \\epsilon_{415}^{\\mathrm{Hb}} \\cdot C_{\\mathrm{Hb}} \\cdot l$$\nSubstituting the numerical values:\n$$A_{\\mathrm{Hb, 415}} = (4.0 \\times 10^{4}\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}\\,\\mathrm{cm}^{-1}) \\times (8.6258 \\times 10^{-5}\\,\\mathrm{mol}\\,\\mathrm{L}^{-1}) \\times (0.50\\,\\mathrm{cm})$$\n$$A_{\\mathrm{Hb, 415}} \\approx 1.7252$$\nThe bias, $b$, is defined as:\n$$b = \\frac{A_{\\mathrm{meas}} - A_{\\mathrm{true}}}{A_{\\mathrm{true}}} = \\frac{(A_{\\mathrm{true}} + A_{\\mathrm{Hb, 415}}) - A_{\\mathrm{true}}}{A_{\\mathrm{true}}} = \\frac{A_{\\mathrm{Hb, 415}}}{A_{\\mathrm{true}}}$$\nSubstituting the values for $A_{\\mathrm{Hb, 415}}$ and $A_{\\mathrm{true}}$:\n$$b = \\frac{1.7252}{0.600} \\approx 2.8753$$\nRounding to three significant figures as requested, the bias is:\n$$b \\approx 2.88$$\nThis indicates an overestimation of the true absorbance by approximately $288\\%$.\n\n**Part 3: Derivation of the Correction Coefficient ($k$)**\n\nThe proposed two-wavelength correction strategy is $A_{\\mathrm{corr}} = A_{415} - k\\,A_{700}$, where $A_{\\mathrm{corr}}$ should be equal to $A_{\\mathrm{true}}$. $A_{415}$ and $A_{700}$ are the total measured absorbances at the respective wavelengths.\nThe measured absorbance at $415\\,\\mathrm{nm}$ is:\n$$A_{415} = A_{\\mathrm{true}} + A_{\\mathrm{Hb, 415}} = A_{\\mathrm{true}} + \\epsilon_{415}^{\\mathrm{Hb}} C_{\\mathrm{Hb}} l$$\nThe problem states that the ELISA chromogen has negligible absorbance at $700\\,\\mathrm{nm}$. Therefore, the measured absorbance at $700\\,\\mathrm{nm}$ is due solely to hemoglobin:\n$$A_{700} = A_{\\mathrm{Hb, 700}} = \\epsilon_{700}^{\\mathrm{Hb}} C_{\\mathrm{Hb}} l$$\nWe set the corrected absorbance equal to the true absorbance and substitute the expressions for $A_{415}$ and $A_{700}$:\n$$A_{\\mathrm{true}} = A_{415} - k\\,A_{700}$$\n$$A_{\\mathrm{true}} = (A_{\\mathrm{true}} + \\epsilon_{415}^{\\mathrm{Hb}} C_{\\mathrm{Hb}} l) - k (\\epsilon_{700}^{\\mathrm{Hb}} C_{\\mathrm{Hb}} l)$$\nSubtracting $A_{\\mathrm{true}}$ from both sides leaves the equation for the interfering components:\n$$0 = (\\epsilon_{415}^{\\mathrm{Hb}} C_{\\mathrm{Hb}} l) - k (\\epsilon_{700}^{\\mathrm{Hb}} C_{\\mathrm{Hb}} l)$$\n$$k (\\epsilon_{700}^{\\mathrm{Hb}} C_{\\mathrm{Hb}} l) = \\epsilon_{415}^{\\mathrm{Hb}} C_{\\mathrm{Hb}} l$$\nSince hemolysis occurred, $C_{\\mathrm{Hb}} > 0$. The path length $l > 0$. We can divide both sides by $C_{\\mathrm{Hb}} l$:\n$$k \\cdot \\epsilon_{700}^{\\mathrm{Hb}} = \\epsilon_{415}^{\\mathrm{Hb}}$$\nSolving for the correction coefficient $k$:\n$$k = \\frac{\\epsilon_{415}^{\\mathrm{Hb}}}{\\epsilon_{700}^{\\mathrm{Hb}}}$$\nThis shows that $k$ is the ratio of the interferent's molar absorptivities at the analytical and reference wavelengths. Substituting the given values:\n$$k = \\frac{4.0 \\times 10^{4}\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}\\,\\mathrm{cm}^{-1}}{80\\,\\mathrm{L}\\,\\mathrm{mol}^{-1}\\,\\mathrm{cm}^{-1}} = 500$$\nThe problem requires rounding $k$ to three significant figures. The exact value is $500$. To represent this with three significant figures unambiguously, we use scientific notation: $5.00 \\times 10^2$. However, since $500$ is a simple integer, and the formatting rules do not strictly enforce scientific notation for such numbers, presenting it as $500$ is acceptable when context implies three significant figures based on the prompt's instruction. Given the requested formats, `500` is the most direct answer, with the understanding that its precision is three significant figures as specified. For maximal clarity in the final answer box, and following standard scientific practice for indicating precision, `$5.00 \\times 10^2$` is the most rigorous representation.\n\nThe final answers are the bias $b \\approx 2.88$ and the correction coefficient $k = 500$, reported to three significant figures.", "answer": "$$\\boxed{\\begin{pmatrix} 2.88  5.00 \\times 10^{2} \\end{pmatrix}}$$", "id": "5164416"}]}